BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31626715)

  • 1. LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.
    Blazquez R; Rietkötter E; Wenske B; Wlochowitz D; Sparrer D; Vollmer E; Müller G; Seegerer J; Sun X; Dettmer K; Barrantes-Freer A; Stange L; Utpatel K; Bleckmann A; Treiber H; Bohnenberger H; Lenz C; Schulz M; Reimelt C; Hackl C; Grade M; Büyüktas D; Siam L; Balkenhol M; Stadelmann C; Kube D; Krahn MP; Proescholdt MA; Riemenschneider MJ; Evert M; Oefner PJ; Klein CA; Hanisch UK; Binder C; Pukrop T
    Int J Cancer; 2020 Jun; 146(11):3170-3183. PubMed ID: 31626715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
    Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
    Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).
    Zirkel A; Lederer M; Stöhr N; Pazaitis N; Hüttelmaier S
    Nucleic Acids Res; 2013 Jul; 41(13):6618-36. PubMed ID: 23677615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin Inhibits Lef1 and Resensitizes Docetaxel-Resistant Breast Cancer Cells.
    Prieto-Vila M; Shimomura I; Kogure A; Usuba W; Takahashi RU; Ochiya T; Yamamoto Y
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32492961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
    Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
    J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.
    Mezencev R; Matyunina LV; Jabbari N; McDonald JF
    BMC Cancer; 2016 Mar; 16():236. PubMed ID: 26988558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.
    Xiao L; Zhang C; Li X; Jia C; Chen L; Yuan Y; Gao Q; Lu Z; Feng Y; Zhao R; Zhao X; Cheng S; Shu Z; Xu J; Duan W; Nie G; Hou Y
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.
    Christova T; Mojtahedi G; Hamel PA
    Int J Biochem Cell Biol; 2010 May; 42(5):630-40. PubMed ID: 20006729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
    Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
    Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
    Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
    Shimomura A; Takasaki A; Nomura R; Hayashi N; Senda T
    Med Mol Morphol; 2013 Mar; 46(1):14-9. PubMed ID: 23325550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
    Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
    EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
    Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
    Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: A redox signaling perspective.
    Monteiro HP; Rodrigues EG; Amorim Reis AKC; Longo LS; Ogata FT; Moretti AIS; da Costa PE; Teodoro ACS; Toledo MS; Stern A
    Nitric Oxide; 2019 Aug; 89():1-13. PubMed ID: 31009708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
    Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
    Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling.
    Sun HF; Yang XL; Zhao Y; Tian Q; Chen MT; Zhao YY; Jin W
    Cancer Lett; 2019 Jan; 440-441():189-201. PubMed ID: 30393159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA
    Yang J; Lin X; Jiang W; Wu J; Lin L
    DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.